Literature DB >> 15337545

Regional radiotherapy to axilla and supraclavicular fossa for adjuvant breast treatment: a comparison of four techniques.

Catherine R Jephcott1, Scott Tyldesley, Carrie-Lynne Swift.   

Abstract

PURPOSE: The three techniques commonly used to treat the axilla and supraclavicular nodes in adjuvant radiotherapy all have significant disadvantages, including underdosing the deeper nodes, excessively irradiating normal tissues, or producing undesirable hot spots. We assessed whether an anterior field with posterior boost field to the axilla with customized compensation of the anterior beam (APcomp-PAboost) would minimize these drawbacks. METHODS AND MATERIALS: The axillary and supraclavicular nodal volumes, planning target volume (PTV), irradiated volume, and brachial plexus were contoured for 10 patients. The plans for each technique-single anterior field (AP); anterior to posterior parallel pair (AP-PA); anterior field with posterior boost (AP-PAboost); and APcomp-PAboost-were then generated for each patient using CadPlan and compared.
RESULTS: The AP plan gave poor PTV coverage in 60% of cases. The AP-PA provided good PTV coverage and minimal hot spots, but resulted in consistent unnecessary RT to the medial posterior neck. The skin and tissue of the medial posterior neck and chest wall (i.e., the tissue overlying the posterior half of the ribs and posterior to the latissimus dorsi muscle, which forms the posterior wall of the axilla) was incidentally included in the radiation fields of the AP-PA and the exit of the AP beam. No nodal tissue is present in this region, and, therefore, this tissue was unnecessarily irradiated to higher doses with the AP-PA technique. The AP-PAboost provided adequate PTV coverage and a limited dose to the medial posterior neck, but produced hot spots in excess of 120% in 90% of cases. The APcomp-PAboost provided good PTV coverage, a limited dose to the medial posterior neck, and hot spots to <120% in all cases.
CONCLUSION: In most cases, the APcomp-PAboost technique offered the best compromise, but the AP-PA technique may be preferred if a less intense hot spot is sought.

Entities:  

Mesh:

Year:  2004        PMID: 15337545     DOI: 10.1016/j.ijrobp.2004.02.057

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  6 in total

1.  Comparison of CT-volumed supraclavicular fossa radiotherapy planning and conventional simulator-planned defined by bony landmarks for early breast cancer.

Authors:  Adrian Murray Brunt; Susan Lupton; Karen Thorley; Lynda Pearce; Julia Handley
Journal:  Rep Pract Oncol Radiother       Date:  2016-03-28

Review 2.  Should the management of radiation therapy for breast cancer be standardized? Results of a survey on current French practices in breast radiotherapy.

Authors:  Martin Schmitt; Jordan Eber; Delphine Antoni; Georges Noel
Journal:  Rep Pract Oncol Radiother       Date:  2021-09-30

3.  Treatment optimization using computed tomography-delineated targets should be used for supraclavicular irradiation for breast cancer.

Authors:  Raweewan Liengsawangwong; Tse-Kuan Yu; Tzouh-Liang Sun; Jeremy J Erasmus; George H Perkins; Welela Tereffe; Julia L Oh; Wendy A Woodward; Eric A Strom; Mohammad Salephour; Thomas A Buchholz
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-11-01       Impact factor: 7.038

Review 4.  Radiation therapy planning with photons and protons for early and advanced breast cancer: an overview.

Authors:  Damien C Weber; Carmen Ares; Antony J Lomax; John M Kurtz
Journal:  Radiat Oncol       Date:  2006-07-20       Impact factor: 3.481

5.  Regional lymph node radiotherapy in breast cancer: single anterior supraclavicular field vs. two anterior and posterior opposed supraclavicular fields.

Authors:  Mohammad Houshyari; Amir Shahram Yousefi Kashi; Sakineh Soleimani Varaki; Afshin Rakhsha; Eftekhar Rajab Blookat
Journal:  Electron Physician       Date:  2015-06-05

6.  Whole breast and regional nodal irradiation in prone versus supine position in left sided breast cancer.

Authors:  Pieter Deseyne; Bruno Speleers; Wilfried De Neve; Bert Boute; Leen Paelinck; Tom Van Hoof; Joris Van de Velde; Annick Van Greveling; Chris Monten; Giselle Post; Herman Depypere; Liv Veldeman
Journal:  Radiat Oncol       Date:  2017-05-26       Impact factor: 3.481

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.